Supplementary Figure 1: ATP1A1 variants with in-frame deletions are enriched in ouabain-resistant cell populations.
From: Marker-free coselection for CRISPR-driven genome editing in human cells

(a) Total editing efficacy along with spectrum and frequency of individual indels as determined by the TIDE assay in K562 cells treated with ATP1A1 G2 sgRNA. Analysis was performed on genomic DNA samples shown in Figure 1b. (b) Same as (a) but for ATP1A1 G4 sgRNA. (c) Same as (a) but for ATP1A1 G3 sgRNA.